Skip to main content

Advertisement

SpringerLink
Log in

The role of tonsillectomy in IgA nephropathy

  • Review
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

The IgA nephropathy (IgAN) is a very common glomerulonephritis and can result in end-stage renal disease. From a clinical point of view, IgAN is characterised by repeated events of macrohaematuria associated with infections of the upper airways. In IgAN, the IgA released by the tonsillar lymphatic tissue into blood circulation are defective in glycosylation. These aberrant IgA can reach the glomeruli and deposit into mesangium causing an inflammation with cellular proliferation. The treatment is not yet well defined: steroids and immunosuppressive drugs are suggested in cases with a progressive disease. Tonsillectomy was proposed to reduce the infective events of upper airways and the lymphatic tissue producing undergalactosylated IgA. The experiences in literature coming from Asia report positive effects of tonsillectomy on IgAN. In patients with tonsillectomy, the renal signs improved (less haematuria and proteinuria) and the renal outcome was better (slower progression of renal damage). These were uncontrolled studies and tonsillectomy was associated with steroid and immunosuppressive treatment, so it is not possible to tell the real effect of tonsillectomy. In contrast, the European studies reported that the tonsillectomy was not associated with a better outcome of IgAN. A critical review of the subject reveals that most of the papers with positive results were uncontrolled retrospective experiences, while in a randomised controlled trial paper the advantages of tonsillectomy disappeared. In conclusion, this review, in agreement with the international guidelines, concludes that tonsillectomy does not play any role in the progression of IgAN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368(25):2402–2414

    Article  PubMed  CAS  Google Scholar 

  2. Donadio JV, Grande JP (2002) IgA nephropathy. New Engl J Med 347(10):738

    Article  PubMed  CAS  Google Scholar 

  3. Berthoux FC, Mohey H, Afiani A (2008) natural history of primary IgA nephropathy. Seminars Nephrol 28:4–8

    Article  Google Scholar 

  4. Haas M (2007) IgA nephropathy and Henoch-Schonlein purpura in Heptinstall’s Pathology of the kidney. In: Jennette J, Olson J, Schwartz M, Silva F (eds) 6th edn. Lippincott Williams & Wilkins, philadelphia

  5. A working Group of the International IgA Nephropathy Network and the Renal Pathology (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int, pp 534–43

  6. VALIGA study of the ERA-EDTA Immunonephrology Working Group (2014) Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int 86(4):828–836. doi:10.1038/ki.2014.63

    Article  Google Scholar 

  7. KDIGO 2012 (2013) Clinical Practice Guideline for the Evaluation and Management. Kidney Int 3

  8. Goto M, Wakai K, Kawamura T et al (2009) A scoring system to predict renal outcome in IgA nephropathy: a nation wide 10 years prospective cohort study. Nephrol Dial Transpl 24:3068–3074

    Article  Google Scholar 

  9. Coppo R, Peruzzi L, Amore A et al (2007) IgACE a placebo controlled randomized trial of angiotensin converting enzyme inhibitors in children and young people with IgAN and a moderate proteinuria. J Am Soc Nephrol 18:1880–1888

    Article  PubMed  CAS  Google Scholar 

  10. Pozzi C, Andrulli S, Del Vecchio L et al (2004) Corticosteroid effectiveness in IgAN: long–term results of a randomisez controlled trial. J Am Soc Nephrol 15:157–163

    Article  PubMed  CAS  Google Scholar 

  11. Béné MC, Faure GC, Hurault de Ligny B et al (2004) Clinical involvement of the tonsillar immune system in IgA nephropathy. Acta Otolaryngol Suppl

  12. Novak J, Julian BA, Mestecky J et al (2012) Glycosilation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 34:365–382

    Article  PubMed  CAS  Google Scholar 

  13. Hiki Y, Akihiko A, Yamamoto Y et al (2011) IgA nephropathy and aberrant glycpsylation of tonsillar, serum and glomerular IgA1. Adv Otorhinolaryngol 72:68–70

    PubMed  Google Scholar 

  14. Rasmussen SB, Reinert LS, Paludan SR (2009) Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS. 117:323–337

    Article  PubMed  CAS  Google Scholar 

  15. Hellings P, Jorissen M, Ceuppens JL (2000) The Waldeyer’s ring. Acta Otorhinolaryngol 54:237–241

    CAS  Google Scholar 

  16. Woof JM, Russel MW (2011) Structure and function relationships in IgA. Mucosal Immunol 4:590–597

    Article  PubMed  CAS  Google Scholar 

  17. Novak J, Moldoveanu Z, Julian BA et al (2011) Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system. Adv Otorhinolaryngol 72:60–63

    PubMed  Google Scholar 

  18. Lai KN (2012) Pathogenesis of IgA nephropathy. Nat Rev Nephrol 8:275–283

    Article  PubMed  CAS  Google Scholar 

  19. Canetta PA, Krzysztof K, Appel GB (2014) Glomerular diseases: emerging tests and therapies for IgA nephropathy. Clin J Am Soc Nephrol 9:617–625

    Article  PubMed  PubMed Central  Google Scholar 

  20. Johansson E, Hultcrantz E (2003) Tonsillectomy- clinical consequences twenty years after surgery? Inter Pediatrics Otorhin. 67:981–988

    Article  Google Scholar 

  21. Suzuki Y, Suzuki H, Nakata J (2011) Pathological role of tonsillar B cells in IgA nephropathy. Clinical Dev Immunol 2011:639074. doi:10.1155/2011/639074

    Article  Google Scholar 

  22. Xie Y, Chen X, Nishi S, Narita I et al (2004) Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int 65:1135–1144

    Article  PubMed  CAS  Google Scholar 

  23. Zielnik-Jurkiewicz B, Jurkiewicz D (2002) Implication of immunological abnormalities after adenotonsillotomy. Int J Pediatr Otorhinolaryngol 64:127–132

    Article  PubMed  Google Scholar 

  24. Zand L, Fervenza FC (2014) Does tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy?. Nephrol Dial Transpl

  25. Vergano L, Loiacono E, Albera R et al (2015) Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? J Nephrol 28:51–58

    Article  PubMed  Google Scholar 

  26. Santos FP, Weiber R, Fortes BC et al (2013) Short and long term impact of adenotonsillectomy on the immune system. Braz J Otorhinolaryngol 79(1):28–34

    Article  PubMed  Google Scholar 

  27. Tamura S, Masuda Y, Inokuchi I et al (1993) Effect of and indication for tonsillectomy in IgA nephropathy. Acta Otoryngol Suppl 508:23–28

    Article  CAS  Google Scholar 

  28. Komatsu H, Fujimoto S, Hara S et al (2008) Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol 3:1301–1307

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  29. Piccoli A, Codognotto M, Tabbi MG et al (2010) Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis. Nephrol Dial Transpl 25:2583–2589

    Article  Google Scholar 

  30. Xie Y, Nishi S, Ueno M et al (2003) The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 63:1861–1867

    Article  PubMed  Google Scholar 

  31. Maeda I, Hayashi T, Sato KK et al (2012) Tonsillectomy Has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy. Nephrol Dial Transplant 27:2806–2813

    Article  PubMed  Google Scholar 

  32. Kawaguchi T, Ieiri N, Yamazaki S et al (2010) Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular hematuria and minimal proteinuria. Nephrology 15:116–123

    Article  PubMed  CAS  Google Scholar 

  33. Rasche FM, Schwarz A, Keller F (1999) Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol 51:147–152

    PubMed  CAS  Google Scholar 

  34. Yamamoto Y, Hiki Y, Nakai NS et al (2013) Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy. Clin Exp Nephrol 17:218–224

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  35. Chen Y, Tang Z, Wang Q et al (2007) Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am J Nephrol 27:170–175

    Article  PubMed  Google Scholar 

  36. Kawamura T, Yoshimura M, Miyazaki Y et al (2014) A multicenter randomized trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transpl 29:1546–1553

    Article  CAS  Google Scholar 

  37. Hotta O, Miyazaki M, Furuta T et al (2001) Tonsillectomy and steroid pulse therapy: tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 38:736–743

    Article  PubMed  CAS  Google Scholar 

  38. Miura N, Imai H, Kikuchi S, Hayashi S (2009) Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy; a national wide survey of TPS therapy in Japanese and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol 13:460–466

    Article  PubMed  CAS  Google Scholar 

  39. Kent D, Tazeen H, Hayard R (2007) Progression risk, urinary protein excretion and treatment effects of angiotensin converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol 18:1959–1965

    Article  PubMed  CAS  Google Scholar 

  40. Tsuchiya T, Ito S, Yamaguchi Y et al (2010) Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft. Clin Nephrol 64:68–71

    Article  Google Scholar 

  41. Coppo R (2010) Can a dysregulated mucosal immune system in IgA nephropathy be controlled by tonsillectomy? Nephrol Dial Transplant 25:2395–2397

    Article  PubMed  CAS  Google Scholar 

  42. Ponticelli C (2012) Tonsillectomy and IgA nephritis. Nephrol Dial Transpl 27:2610–2613

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UOC Nephrology and Dialysis, Nephrology and Dialysis Dpt, Belcolle Hospital, Strada Sammartinese snc, 01100, Viterbo, Italy

    Sandro Feriozzi & Rosaria Polci

Authors
  1. Sandro Feriozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosaria Polci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandro Feriozzi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feriozzi, S., Polci, R. The role of tonsillectomy in IgA nephropathy. J Nephrol 29, 13–19 (2016). https://doi.org/10.1007/s40620-015-0247-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-015-0247-4

Keywords

Search

Navigation